EU Approved..Europe Federation Says Firdape Is First-Line Treatment, $2's Undervalued !
Article : Strong Comps Indicate Catalyst Pharmaceutical Partners Outstanding Value Proposition
By: Charlie Bucks
Firdapse is a strong contender for approval for several reasons. First, Firdapse has already been approved in the EU and is now selling in Europe. Second, the European Federation of Neurological Societies recommends Firdapse™ as First-Line Treatment for LEMS